Rosuvastatin Calcium

CAS 147098-20-2 44 current records 5 historicalSmall Molecule

Who holds supplier records for Rosuvastatin Calcium? 44 organisations hold a current record for Rosuvastatin Calcium: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 30 of them hold a valid EU Certificate of Suitability (32 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (26), China (7), Slovenia (2), Netherlands (2) and 3 other countries (3); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rosuvastatin Calcium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rosuvastatin-calcium

Reading the evidence

  • 44 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    26 of the 40 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 17 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (44)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rosuvastatin Calcium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India26China7Slovenia2Netherlands2Canada1South Korea1Germany1Country not recorded for 4
Need Rosuvastatin Calcium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (32)

Certificates of Suitability on the EDQM register for Rosuvastatin Calcium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 69 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
GRUENENTHAL GMBH AachenDE
CEP 2025-347 - Rev 00
Rosuvastatin calcium, Milled
Oct 2026Inspected Nov 2024
Germany
MSN LABORATORIES PRIVATE LIMITED SangareddyIN
CEP 2026-268 - Rev 00
Rosuvastatin calcium, Route code “QVR”, Amorphous Form, Micronised
Sept 2026—
MELODY HEALTHCARE PRIVATE LIMITED MumbaiIN
CEP 2023-145 - Rev 01
Rosuvastatin calcium, Process II
Sept 2026—
REINE LIFESCIENCE AnkleshwarIN
CEP 2025-505 - Rev 00
Rosuvastatin calcium
Sept 2026—
NINGBO MENOVO PHARMACEUTICAL CO., LTD. NingboCN
CEP 2025-486 - Rev 01
Rosuvastatin calcium, Process III
Sept 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2026-213 - Rev 00
Rosuvastatin calcium, (Amorphous)- Process-II
Jul 2026—
Changzhou Pharmaceutical Factory ChangzhouCN
CEP 2020-430 - Rev 03
Rosuvastatin calcium, Route Code: RSF, Amorphous form
Jul 2026Inspected Apr 2025
Italy
CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. DelftNL
CEP 2015-090 - Rev 03
Rosuvastatin calcium
Jun 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2018-227 - Rev 02
Rosuvastatin calcium
Jun 2026—
BIOCON LIMITED BengaluruIN
CEP 2024-354 - Rev 01
Rosuvastatin calcium, Process-III
Jun 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2016-175 - Rev 02
Rosuvastatin calcium
May 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2023-356 - Rev 01
Rosuvastatin calcium, 1518
Jan 2026—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2017-069 - Rev 05
Rosuvastatin calcium, Amorphous
Jan 2026—
CTX LIFESCIENCES PVT. LIMITED SuratIN
CEP 2025-419 - Rev 00
Rosuvastatin calcium, RS02
Oct 2025—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2025-379 - Rev 00
Rosuvastatin calcium, Process-II
Oct 2025—
KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mestoSI
CEP 2025-290 - Rev 00
Rosuvastatin calcium, 000757, milled
Oct 2025Inspected Jul 2025
Slovenia
SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. ShangyuCN
CEP 2019-309 - Rev 03
Rosuvastatin calcium
Sept 2025—
ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai CityCN
CEP 2023-066 - Rev 01
Rosuvastatin calcium, Site 2
Aug 2025Inspected Oct 2025
France
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2022-009 - Rev 02
Rosuvastatin calcium
Jul 2025—
MANKIND PHARMA LIMITED New DelhiIN
CEP 2022-060 - Rev 02
Rosuvastatin calcium, Micronised
Jul 2025—
TAPI NL B.V. AmsterdamNL
CEP 2017-018 - Rev 01
Rosuvastatin calcium, Process G 2410
Jul 2025—
ZHEJIANG LEPU PHARMACEUTICAL CO., LTD Taizhou CityCN
CEP 2020-243 - Rev 01
Rosuvastatin calcium
May 2025—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2025-007 - Rev 00
Rosuvastatin calcium, Process 4
Mar 2025Inspected Mar 2026
Spain
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2024-400 - Rev 01
Rosuvastatin calcium, AM code
Feb 2025—
LEWENS LABS PRIVATE LIMITED DahejIN
CEP 2022-473 - Rev 00
Rosuvastatin calcium
Jul 2024—
MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor VillageIN
CEP 2020-057 - Rev 01
Rosuvastatin calcium
Mar 2024—
MOREPEN LABORATORIES LIMITED New DelhiIN
R1-CEP 2017-153 - Rev 00
Rosuvastatin calcium, Process 2
Jun 2023—
INNOVARE LABS PRIVATE LIMITED VisakhapatnamIN
R0-CEP 2021-165 - Rev 00
Rosuvastatin calcium
Jan 2023—
LEE PHARMA LIMITED HyderabadIN
R0-CEP 2022-204 - Rev 00
Rosuvastatin calcium
Dec 2022—
RUYUAN HEC PHARM CO., LTD. ShaoguanCN
R1-CEP 2015-356 - Rev 00
Rosuvastatin calcium
Oct 2022—
Changzhou Pharmaceutical Factory Jiangsu ProvinceCN
R1-CEP 2015-240 - Rev 00
Rosuvastatin calcium
Jul 2021—
SHREEGEN PHARMA LIMITED HyderabadIN
R0-CEP 2018-112 - Rev 00
Rosuvastatin calcium
Oct 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Rosuvastatin Calcium are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rosuvastatin Calcium is a statin medication used to treat high cholesterol and to prevent cardiovascular disease. It works by inhibiting the enzyme HMG-CoA reductase in the liver, thereby reducing cholesterol levels in the blood.

Chemical identity

IUPAC name
calcium bis((E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate)
Canonical SMILES
CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]
InChIKey
BPRHUIZQVSMCRT-INIZCTEOSA-L
Synonyms
Crestor API

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Therapeutic areas

CardiovascularMetabolic Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rosuvastatin Calcium?

44 organisations hold an active US FDA Type II Drug Master File or a CEP for Rosuvastatin Calcium: Biocon Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), CHROMO LABORATORIES INDIA PRIVATE LTD (India), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), Lek Pharmaceuticals D.D. (Slovenia) and CENTRIENT PHARMACEUTICALS NETHERLANDS BV (Netherlands), and 36 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rosuvastatin Calcium Drug Master Files are active?

Biocon Limited (DMF 27675, 40077), ALIVUS LIFE SCIENCES LTD (DMF 28888, 20592), APITORIA PHARMA PRIVATE LTD (DMF 40523, 20629), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 20705, 34974), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 36208, 37220), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 32794, 42285), Lek Pharmaceuticals D.D. (DMF 20765, 30932) and CENTRIENT PHARMACEUTICALS NETHERLANDS BV (DMF 31410) and 26 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rosuvastatin Calcium records mean?

5 organisations have only inactive Type II DMFs for Rosuvastatin Calcium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Rosuvastatin Calcium have a European Certificate of Suitability?

Yes. 30 organisations hold a valid CEP for Rosuvastatin Calcium on the EDQM register, including GRUENENTHAL GMBH Aachen (DE), MSN LABORATORIES PRIVATE LIMITED Sangareddy (IN), MELODY HEALTHCARE PRIVATE LIMITED Mumbai (IN), REINE LIFESCIENCE Ankleshwar (IN), NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo (CN) and HETERO DRUGS LIMITED Hyderabad (IN) and 26 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rosuvastatin Calcium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rosuvastatin Calcium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.